The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals

被引：13

作者：

Salvado, Gemma ^{[1
,2
]}

Ferreira, Daniel ^{[3
,4
]}

Operto, Gregory ^{[1
,2
,5
]}

Cumplido-Mayoral, Irene ^{[1
,6
]}

Arenaza-Urquijo, Eider M. ^{[1
,2
,5
]}

Cacciaglia, Raffaele ^{[1
,2
,5
]}

Falcon, Carles ^{[1
,2
,7
]}

Vilor-Tejedor, Natalia ^{[1
,6
,8
,9
]}

Minguillon, Carolina ^{[1
,2
,5
]}

Groot, Colin ^{[10
]}

van der Flier, Wiesje M. ^{[10
,11
]}

Barkhof, Frederik ^{[12
,13
,14
]}

Scheltens, Philip ^{[10
]}

Ossenkoppele, Rik ^{[10
,15
]}

Kern, Silke ^{[16
]}

Zettergren, Anna ^{[16
]}

Skoog, Ingmar ^{[16
]}

Hort, Jakub ^{[17
,18
,19
]}

Stomrud, Erik ^{[20
,21
]}

van Westen, Danielle ^{[22
,23
]}

Hansson, Oskar ^{[20
,21
]}

Molinuevo, Jose Luis ^{[1
]}

Wahlund, Lars-Olof ^{[3
]}

Westman, Eric ^{[3
,24
]}

Gispert, Juan Domingo ^{[1
,2
,6
,7
]}

机构：

[1] Pasqual Maragall Fdn, Barcelona Beta Brain Res Ctr BBRC, Barcelona, Spain

[2] IMIM Hosp del Mar Med Res Inst, Barcelona, Spain

[3] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden

[4] Mayo Clin, Dept Radiol, Rochester, MN USA

[5] CIBER Fragilidad & Envejecimiento Saludable CIBER, Madrid, Spain

[6] Univ Pompeu Fabra, Barcelona, Spain

[7] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Madrid, Spain

[8] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Barcelona, Spain

[9] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands

[10] Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam UMC,Amsterdam Neurosci, Amsterdam, Netherlands

[11] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam UMC, Amsterdam Neurosci, Amsterdam, Netherlands

[12] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Neurosci Campus Amsterdam, Amsterdam, Netherlands

[13] UCL, Inst Neurol, London, England

[14] UCL, Inst Healthcare Engn, London, England

[15] Lund Univ, Clin Memory Res Unit, Lund, Sweden

[16] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol,Neuropsychiat Epidemiol U, Dept Psychiat & Neurochem,Ctr Ageing & Hlth AgeCa, Gothenburg, Sweden

[17] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic

[18] Charles Univ Prague, Fac Med 2, Dept Neurol, Memory Clin, Prague, Czech Republic

[19] Motol Univ Hosp, Prague, Czech Republic

[20] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden

[21] Skane Univ Hosp, Memory Clin, Malmo, Sweden

[22] Lund Univ, Inst Clin Sci, Diagnost Radiol, Lund, Sweden

[23] Skane Univ Hosp, Image & Funct, Lund, Sweden

[24] Kings Coll London, Ctr Neuroimaging Sci, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England

来源：

ALZHEIMERS & DEMENTIA | 2022年 / 18卷 / 07期

基金：

瑞典研究理事会; 加拿大健康研究院; 美国国家卫生研究院;

关键词：

Alzheimer's disease; Alzheimer's disease signature; apolipoprotein E epsilon 2 carrier; brain maintenance; brain morphology; brain reserve; cognitive reserve; magnetic resonance; multi-site; resilience signature; APOLIPOPROTEIN-E; HIPPOCAMPAL VOLUME; ALZHEIMER-DISEASE; MRI; DEMENTIA; YOUNG; NEURODEGENERATION; MECHANISMS; PATHOLOGY; CARRIERS;

D O I：

10.1002/alz.12487

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction: Harboring two copies of the apolipoprotein E (APOE) epsilon 2 allele strongly protects against Alzheimer's disease (AD). However, the effect of this genotype on gray matter (GM) volume in cognitively unimpaired individuals has not yet been described. Methods: Multicenter brain magnetic resonance images (MRIs) from cognitively unimpaired epsilon 2 homozygotes were matched (1:1) against all other APOE genotypes for relevant confounders (n = 223). GM volumes of epsilon 2 genotypic groups were compared to each other and to the reference group (APOE epsilon 3/epsilon 3). Results: Carrying at least one epsilon 2 allele was associated with larger GM volumes in brain areas typically affected by AD and also in areas associated with cognitive resilience. APOE epsilon 2 homozygotes, but not APOE epsilon 2 heterozygotes, showed larger GM volumes in areas related to successful aging. Discussion: In addition to the known resistance against amyloid-beta deposition, the larger GM volumes in key brain regions may confer APOE epsilon 2 homozygotes additional protection against AD-related cognitive decline.

引用

页码：1383 / 1395

页数：13

共 43 条

[1] Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults
Alexander, Gene E.
Bergfield, Kaitlin L.
Chen, Kewei
Reiman, Eric M.
Hanson, Krista D.
Lin, Lan
Bandy, Daniel
Caselli, Richard J.
Moeller, James R.
[J]. NEUROBIOLOGY OF AGING, 2012, 33 (12) : 2723 - 2732
[2] Hippocampal Volume Differences Between Healthy Young Apolipoprotein E ε2 and ε4 Carriers
Alexopoulos, Panagiotis
Richter-Schmidinger, Tanja
Horn, Marco
Maus, Sebastian
Reichel, Martin
Sidiropoulos, Christos
Rhein, Cosima
Lewczuk, Piotr
Doerfler, Arnd
Kornhuber, Johannes
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 (02) : 207 - 210
[3] The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies
Arenaza-Urquijo, Eider M.
Przybelski, Scott A.
Lesnick, Timothy L.
Graff-Radford, Jonathan
Machulda, Mary M.
Knopman, David S.
Schwarz, Christopher G.
Lowe, Val J.
Mielke, Michelle M.
Petersen, Ronald C.
Jack, Clifford R., Jr.
Vemuri, Prashanthi
[J]. BRAIN, 2019, 142 : 1134 - 1147
[4] Dissociation of neuropathologic findings and cognition -: Case report of an apolipoprotein e ε2/ε2 genotype
Berlau, Daniel J.
Kahle-Wrobleski, Kristin
Head, Elizabeth
Goodus, Matthew
Kim, Ronald
Kawas, Claudia
[J]. ARCHIVES OF NEUROLOGY, 2007, 64 (08) : 1193 - 1196
[5] APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old
Berlau, Daniel J.
Corrada, Maria M.
Head, Elizabeth
Kawas, Claudia H.
[J]. NEUROLOGY, 2009, 72 (09) : 829 - 834
[6] Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, Guojun
[J]. NATURE REVIEWS NEUROSCIENCE, 2009, 10 (05) : 333 - 344
[7] Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease
Cacciaglia, Raffaele
Luis Molinuevo, Jose
Falcon, Carles
Brugulat-Serrat, Anna
Sanchez-Benavides, Gonzalo
Gramunt, Nina
Esteller, Manel
Moran, Sebastian
Minguillon, Carolina
Fauria, Karine
Domingo Gispert, Juan
[J]. ALZHEIMERS & DEMENTIA, 2018, 14 (07) : 902 - 912
[8] Basic statistical analysis in genetic case-control studies
Clarke, Geraldine M.
Anderson, Carl A.
Pettersson, Fredrik H.
Cardon, Lon R.
Morris, Andrew P.
Zondervan, Krina T.
[J]. NATURE PROTOCOLS, 2011, 6 (02) : 121 - 133
[9] An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Desikan, Rahul S.
Segonne, Florent
Fischl, Bruce
Quinn, Brian T.
Dickerson, Bradford C.
Blacker, Deborah
Buckner, Randy L.
Dale, Anders M.
Maguire, R. Paul
Hyman, Bradley T.
Albert, Marilyn S.
Killiany, Ronald J.
[J]. NEUROIMAGE, 2006, 31 (03) : 968 - 980
[10] The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
Dickerson, Bradford C.
Bakkour, Akram
Salat, David H.
Feczko, Eric
Pacheco, Jenni
Greve, Douglas N.
Grodstein, Fran
Wright, Christopher I.
Blacker, Deborah
Rosas, H. Diana
Sperling, Reisa A.
Atri, Alireza
Growdon, John H.
Hyman, Bradley T.
Morris, John C.
Fischl, Bruce
Buckner, Randy L.
[J]. CEREBRAL CORTEX, 2009, 19 (03) : 497 - 510

← 1 2 3 4 5 →